Abstract:Drug combinations are the basis of treatment for modern diseases but arriving at successful combination therapies is fraught with challenges. Decades ago, the limited number of drugs represented a tractable candidate list from which to design combination experiments. However, the current pool of single-agent drugs to potentially combine is far too large to brute-force screen, and purely computational predictions have performed poorly. Suitable screening methods are needed, but the design of experimental approaches has proven to be highly complex; researchers need to carefully balance many variables such as appropriate drug concentration ranges, number of doses, inclusion of replicates, and throughput. Perhaps the most significant obstacle facing these studies is the approach to data analysis, where conflicting definitions of synergy and unintuitive metrics serve to confuse researchers and render largely uninterpretable results. Collectively, these challenges hamper the progress of drug combination research and ultimately translational impact. To overcome these limitations, we have developed a fully self-contained framework to handle both the experimental design and analysis of drug combination experiments. Our method, called Combocat, provides a straightforward way to test and analyze any number of drug combinations and samples, and is suitable for high-throughput. Combocat provides a high-resolution of concentration combinations compared to most current approaches. This is automated by common instruments and uses scripts included within our protocol. Through careful template design, we were able to include 3 replicates of each 10x10 matrix, single-agent drugs, and controls - all within a single 384-well plate. We found our method to work robustly with varying sample types (Human cancer, bacteria, fungi), and readouts. After data generation, files can simply be dragged into our Combocat analysis tool directly. We provide a free, web-based software suite to fully automate the analysis after data collection. The Combocat web tool is intuitive and facilitates interactive exploration of synergy. It also provides a rich array of information such as dose-response curves, IC50 values, synergy matrices, ranked hit plots, and more. Data normalization, synergy algorithms, scoring functions, and other complex calculations are run swiftly and automatically in the background with no need for user input. Notably, we employ statistical testing by taking advantage of experimental replicates, which is a feature we found lacking in most methods. We use a well-documented synergy metric but also decided to formulate our own Combocat score which considers statistical measurements and assay quality. The Combocat score provides an easy interpretation of results and facilitates quick identification of top hits. Collectively, our platform will be used to enhance and expedite the selection of effective drug combinations. Citation Format: William C. Wright, Min Pan, Hyeong-Min Lee, Gregory A. Phelps, Jonathan Low, Duane Currier, Richard E. Lee, Taosheng Chen, Paul Geeleher. Combocat: A high-throughput framework for drug combination studies [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl) nr 1907.

CAT Bridge: an efficient toolkit for gene-metabolite association mining from multiomics data

CAT Bridge: an efficient toolkit for compound-transcript association mining from multi-omics data

Autonomous Multimodal Metabolomics Data Integration for Comprehensive Pathway Analysis and Systems Biology

Comparative Integrated Omics Approach Sterically Understanding Hepatic Metabolic Dynamics in Mouse Model: DOI: 10.5584/Jiomics.v7i1.200

MMCA: a Web-based Server for the Microbiome and Metabolome Correlation Analysis

Comparative Integrated Omics Approach Sterically Understanding Hepatic Metabolic Dynamics in Mouse Model

An automated data analysis pipeline for GC-TOF-MS metabonomics studies.

Combining CRISPRi and metabolomics for functional annotation of compound libraries

Cat-E: A Comprehensive Web Tool for Exploring Cancer Targeting Strategies

MMEASE: Online meta-analysis of metabolomic data by enhanced metabolite annotation, marker selection and enrichment analysis

GEMCAT – A new algorithm for gene expression-based prediction of metabolic alterations

Abstract 1907: Combocat: A high-throughput framework for drug combination studies

Identifying Gene Function and Module Connections by the Integration of Multispecies Expression Compendia

COMO: a pipeline for multi-omics data integration in metabolic modeling and drug discovery

CViewer: a Java-based statistical framework for integration of shotgun metagenomics with other omics datasets

A multi-dimensional liquid chromatography/high-resolution mass spectrometry approach combined with computational data processing for the comprehensive characterization of the multicomponents from Cuscuta chinensis

Using clusterProfiler to characterize multiomics data

A community resource for paired genomic and metabolomic data mining

Leveraging inter-individual transcriptional correlation structure to infer discrete signaling mechanisms across metabolic tissues

Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas

CACTI: an in silico chemical analysis tool through the integration of chemogenomic data and clustering analysis